FACTX Mutual Fund

NAV$54.91

Fund Essentials - as of Jan 31, 2026

Net Assets
$235M
Expense Ratio
1.18%
Dividend Yield (Current)
13.76%
Holdings
133
Inception Date
Sep 3, 1996
Fund Family
Fidelity Investments (US)
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+9.60%
1 Year+45.75%
3 Year+17.89%
5 Year+9.79%
10 Year+13.54%

Asset Allocation

Stocks: 94.87%
Bonds: 0.17%
Cash: 3.27%
Other: 1.68%

Top Holdings

View All →
TickerNameWeight
BSXBoston Scientific Corp7.14%
LLYEli Lilly & Co6.45%
DHRDanaher Corp.6.25%
JNJJohnson & Johnson3.60%
NMFFidelity Securities Lending Cash Central Fund3.12%
Top 10 Concentration: 39.76%Report Date: Jan 31, 2026
Download all 133 holdings for FACTX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
13.76%
Frequency
Annually
Latest Distribution
$4.15
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

FACTX Mutual Fund Overview

FACTX Mutual Fund (Fidelity Advisor Health Care Fund Class M) is managed by Fidelity Investments (US) with $235.1M in net assets. FACTX expense ratio is 1.18%, holding 133 positions across sectors including Health Care, Unknown, Financials. Inception date: 1996-09-03.

FACTX performance shows a YTD return of 9.60%. The 1-year return is 45.75% and the 5-year return is 9.79%. FACTX dividend yield stands at 13.76%, paid annually.

FACTX top holdings include Boston Scientific Corp (7.1%), Eli Lilly & Co (6.5%), Danaher Corp. (6.3%), Johnson & Johnson (3.6%), Fidelity Securities Lending Cash Central Fund (3.1%). View all FACTX holdings, sector breakdown, or dividend history.

FACTX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FACTX alternatives are available via the screener, along with tax-loss harvesting opportunities.